Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis

Overview of attention for article published in Journal of Crohn's and Colitis Supplements, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#14 of 2,147)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 53 news stories from 47 outlets.

The authors of the expert article published in the Journal of Crohn's and Colitis include major European and North American Key…

The authors of the expert article published in the Journal of Crohn's and Colitis include major European and North American Key…

The authors of the expert article published in the Journal of Crohn's and Colitis include major European and North American Key…

The authors of the expert article published in the Journal of Crohn's and Colitis include major European and North American Key…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 49 additional news stories.